Inducible macrolides-lincosamides-streptogramin B resistance in Bacteroides species

Insights

Inducible macrolides-lincosamides-streptogramin B resistance is now evident in Bacteroides species. Erythromycin resistance in these bacteria was found to correlate with reduced susceptibility to clindamycin.

Area of Science:

  • Microbiology
  • Antimicrobial Resistance
  • Bacteriology

Background:

  • Macrolides-lincosamides-streptogramin B (MLSB) resistance is a growing concern in clinical settings.
  • Bacteroides species are common commensals but can be opportunistic pathogens.
  • Understanding resistance mechanisms in Bacteroides is crucial for effective treatment.

Purpose of the Study:

  • To investigate the presence and characteristics of inducible MLSB resistance in Bacteroides species.
  • To determine the relationship between erythromycin resistance and clindamycin susceptibility in Bacteroides.

Main Methods:

  • Phenotypic testing of Bacteroides isolates for antimicrobial susceptibility.
  • Induction of resistance using different macrolide agents.
  • Analysis of 144 Bacteroides isolates for resistance patterns.

Main Results:

  • The study provides the first evidence of inducible MLSB resistance in Bacteroides species.
  • Exposure to various macrolides induced clindamycin resistance in a previously susceptible Bacteroides vulgatus strain.
  • A significant association was observed between erythromycin resistance and decreased clindamycin susceptibility across 144 isolates.

Conclusions:

  • Inducible MLSB resistance mechanisms are present in Bacteroides species.
  • Erythromycin resistance may serve as an indicator for potential clindamycin resistance in Bacteroides.
  • These findings highlight the need for careful antimicrobial stewardship when treating infections caused by Bacteroides.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...